Risk Solutions for Carriers
Regulus Therapeutics Announces Restructuring of Sanofi and Oxford Loan Agreements Los Angeles JOLLA, Calif. , Aug. 31, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical business dedicated to the development and growth of revolutionary medications focusing on microRNAs, today announced that pursuant to an amendment of its term loan contract with Oxford LLC,…